Search Results - "Farhadi, Shaheen A"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Intra-articular delivery of an indoleamine 2,3-dioxygenase galectin-3 fusion protein for osteoarthritis treatment in male Lewis rats by Partain, Brittany D, Bracho-Sanchez, Evelyn, Farhadi, Shaheen A, Yarmola, Elena G, Keselowsky, Benjamin G, Hudalla, Gregory A, Allen, Kyle D

    Published in Arthritis research & therapy (18-09-2023)
    “…Osteoarthritis (OA) is driven by low-grade inflammation, and controlling local inflammation may offer symptomatic relief. Here, we developed an indoleamine…”
    Get full text
    Journal Article
  2. 2

    Locally anchoring enzymes to tissues via extracellular glycan recognition by Farhadi, Shaheen A., Bracho-Sanchez, Evelyn, Fettis, Margaret M., Seroski, Dillon T., Freeman, Sabrina L., Restuccia, Antonietta, Keselowsky, Benjamin G., Hudalla, Gregory A.

    Published in Nature communications (22-11-2018)
    “…Success of enzymes as drugs requires that they persist within target tissues over therapeutically effective time frames. Here we report a general strategy to…”
    Get full text
    Journal Article
  3. 3

    Hierarchical self-assembly and emergent function of densely glycosylated peptide nanofibers by Restuccia, Antonietta, Seroski, Dillon T., Kelley, Karen L., O’Bryan, Christopher S., Kurian, Justin J., Knox, Kevin R., Farhadi, Shaheen A., Angelini, Thomas E., Hudalla, Gregory A.

    Published in Communications chemistry (06-05-2019)
    “…Glycosylation alters protein form and function by establishing intermolecular forces that mediate specific interactions while preventing non-specific…”
    Get full text
    Journal Article
  4. 4

    A Synthetic Tetramer of Galectin-1 and Galectin-3 Amplifies Pro-apoptotic Signaling by Integrating the Activity of Both Galectins by Farhadi, Shaheen A, Fettis, Margaret M, Liu, Renjie, Hudalla, Gregory A

    Published in Frontiers in chemistry (10-01-2020)
    “…Galectin-1 (G1) and galectin-3 (G3) are carbohydrate-binding proteins that can signal apoptosis in T cells. We recently reported that a synthetic tetramer with…”
    Get full text
    Journal Article
  5. 5

    Physical tuning of galectin-3 signaling by Farhadi, Shaheen A., Liu, Renjie, Becker, Matthew W., Phelps, Edward A., Hudalla, Gregory A.

    “…Galectin-3 (Gal3) exhibits dynamic oligomerization and promiscuous binding, which can lead to concomitant activation of synergistic, antagonistic, or…”
    Get full text
    Journal Article
  6. 6

    Enzymes as Immunotherapeutics by Farhadi, Shaheen A, Bracho-Sanchez, Evelyn, Freeman, Sabrina L, Keselowsky, Benjamin G, Hudalla, Gregory A

    Published in Bioconjugate chemistry (21-03-2018)
    “…Enzymes are attractive as immunotherapeutics because they can catalyze shifts in the local availability of immunostimulatory and immunosuppressive signals…”
    Get full text
    Journal Article
  7. 7

    Engineering galectin–glycan interactions for immunotherapy and immunomodulation by Farhadi, Shaheen A, Hudalla, Gregory A

    “…Galectins, a 15-member family of soluble carbohydrate-binding proteins, are receiving increasing interest as therapeutic targets for immunotherapy and…”
    Get full text
    Journal Article
  8. 8

    Experimental and Computational Models of Transport of Galectin-3 Through Glycosylated Matrix by Piñeiro-Llanes, Janny, Rodriguez, Camille D., Farhadi, Shaheen A., Hudalla, Gregory A., Sarntinoranont, Malisa, Simmons, Chelsey S.

    Published in Annals of biomedical engineering (01-06-2022)
    “…Altered extracellular matrix (ECM) production is a hallmark of many fibroproliferative diseases, including certain cancers. The high incidence of glycan-rich…”
    Get full text
    Journal Article
  9. 9

    A chimeric, multivalent assembly of galectin-1 and galectin-3 with enhanced extracellular activity by Fettis, Margaret M, Farhadi, Shaheen A, Hudalla, Gregory A

    Published in Biomaterials science (23-04-2019)
    “…Galectins are attractive therapeutic candidates to control aberrant immune system activation because they can alter the phenotype and function of various…”
    Get more information
    Journal Article
  10. 10

    Site-Specific Cross-Linking of Galectin-1 Homodimers via Poly(ethylene glycol) Bismaleimide by Kane, Bryant J., Fettis, Margaret M., Farhadi, Shaheen A., Liu, Renjie, Hudalla, Gregory A.

    Published in Cellular and molecular bioengineering (01-10-2021)
    “…Introduction The promise of the natural immunoregulator, Galectin-1 (Gal1), as an immunomodulatory therapeutic is challenged by its unstable homodimeric…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Evaluation of Self-Assembled Glycopeptide Nanofibers Modified with N,N′‑Diacetyllactosamine for Selective Galectin‑3 Recognition and Inhibition by Restuccia, Antonietta, Fettis, Margaret M., Farhadi, Shaheen A., Molinaro, Matthew D., Kane, Bryant, Hudalla, Gregory A.

    Published in ACS biomaterials science & engineering (08-10-2018)
    “…The carbohydrate-binding protein galectin-3 (Gal3) is an attractive drug target due to its role as a modulator of cell behavior in various pathological…”
    Get full text
    Journal Article